» Articles » PMID: 10832063

Manganese-porphyrin Reactions with Lipids and Lipoproteins

Overview
Date 2000 Jun 1
PMID 10832063
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Manganese porphyrin complexes serve to catalytically scavenge superoxide, hydrogen peroxide, and peroxynitrite. Herein, reactions of manganese 5,10,15,20-tetrakis(N-ethylpyridinium-2-yl)porphyrin (MnTE-2-PyP(5+)) with lipids and lipid hydroperoxides (LOOH) are examined. In linoleic acid and human low-density lipoprotein (LDL), MnTE-2-PyP(5+) promotes oxidative reactions when biological reductants are not present. By redox cycling between Mn(+3) and Mn(+4) forms, MnTE-2-PyP(5+) initiates lipid peroxidation via decomposition of 13(S)hydroperoxyoctadecadienoic acid [13(S)HPODE], with a second-order rate constant of 8.9 x 10(3) M(-1)s(-1)and k(cat) = 0.32 s(-1). Studies of LDL oxidation demonstrate that: (i) MnTE-2-PyP(5+) can directly oxidize LDL, (ii) MnTE-2-PyP(5+) does not inhibit Cu-induced LDL oxidation, and (iii) MnTE-2-PyP(5+) plus a reductant partially inhibit lipid peroxidation. MnTE-2-PyP(5+) (1-5 microM) also significantly inhibits FeCl(3) plus ascorbate-induced lipid peroxidation of rat brain homogenate. In summary, MnTE-2-PyP(5+) initiates membrane lipid and lipoprotein oxidation in the absence of biological reductants, while MnTE-2-PyP(5+) inhibits lipid oxidation reactions initiated by other oxidants when reductants are present. It is proposed that, as the Mn(+3) resting redox state of MnTE-2-PyP(5+) becomes oxidized to the Mn(+4) redox state, LOOH is decomposed to byproducts that propagate lipid oxidation reactions. When the manganese of MnTE-2-PyP(5+) is reduced to the +2 state by biological reductants, antioxidant reactions of the metalloporphyrin are favored.

Citing Articles

Differential Activation of Glioprotective Intracellular Signaling Pathways in Primary Optic Nerve Head Astrocytes after Treatment with Different Classes of Antioxidants.

Ghosh A, Rao V, Wisniewski V, Zigrossi A, Floss J, Koulen P Antioxidants (Basel). 2020; 9(4).

PMID: 32316287 PMC: 7222350. DOI: 10.3390/antiox9040324.


Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease.

Ziniauskaite A, Ragauskas S, Ghosh A, Thapa R, Roessler A, Koulen P Ocul Surf. 2019; 17(2):257-264.

PMID: 30807830 PMC: 6570415. DOI: 10.1016/j.jtos.2019.02.006.


Improvements in SOD mimic AEOL-10150, a potent broad-spectrum antioxidant.

Zhang X, Zhou W, Zhang Y Mil Med Res. 2018; 5(1):30.

PMID: 30185231 PMC: 6125955. DOI: 10.1186/s40779-018-0176-3.


An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.

Batinic-Haberle I, Tovmasyan A, Spasojevic I Redox Biol. 2015; 5:43-65.

PMID: 25827425 PMC: 4392060. DOI: 10.1016/j.redox.2015.01.017.


Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.

Tovmasyan A, Carballal S, Ghazaryan R, Melikyan L, Weitner T, Maia C Inorg Chem. 2014; 53(21):11467-83.

PMID: 25333724 PMC: 4220860. DOI: 10.1021/ic501329p.